Blood test to determine gender of the baby. Why not?

Are you a future parent expecting a baby? One of the most exciting things that happen to pregnancy is to know the gender of your little angel. The traditional way of knowing is through ultrasound testing but is there a way of knowing the gender earlier? What is this process? How different would it be from conventional procedures? In this article, I’m going to provide you with information about blood test to determine gender. Blood testing, yes it’s possible!

In the conventional process, you have to be on your fourth or fifth month of pregnancy to determine the baby’s gender. But as early as seven weeks, you can know your baby’s gender through blood testing. This article might sound very technical, but I aim to make you understand that the process might easy to hear but the methods are not.

Blood test to determine gender

Free Cell DNA Testing, What Do You Need to Know?

There is a recent discovery of the presence of fetal generic material in a maternal blood, and it offered new approaches and methods to non-invasive diagnosis. This blood test can detect Down syndrome and other chromosomal disorder at the 10th week of pregnancy, and even later.

Cell-free Fetal DNA originated from trophoblasts making the placenta. There is estimation that 2 to 6% of DNA in maternal blood is originally fetal. It is fragmented and will make its way to the bloodstream through flaking of the placental microparticles. The DNA can be detected as early as seven weeks and the quantity of this DNA increases when the pregnancy progresses.

This test is 92 to 99% accurate in detecting conditions and baby’s gender. The test allows the pregnant women to find out the baby’s condition and gender without taking an invasive procedure like CVS or amniocentesis. Invasive procedures require a needle to be inserted into the woman’s uterus and it has a small risk of miscarriage.

Baby’s DNA in Mother’s Blood

Baby’s DNA in Mother’s Blood (via:

How does it Work?

The procedure counts fragments of baby’s DNA in the mother’s blood. If the results show extra chromosome 21 fragments, then it suggests that there are 3 copies of the certain chromosome instead of normal 2. That indicated Down syndrome or trisomy 21.

For detecting baby’s gender, the predictor is based on detection of the Y chromosome; this is the specific DNA in a maternal blood sample.

Results of Gender Predictor

If the result of the procedure is positive for the presence of Y- chromosome then the baby’s gender is confirmed male.

If the result yields negative presence of Y-chromosome, it means two things. First, the gender of the baby is female. Second, the amount of fetal DNA is very low.

Free Cell DNA



When is test performed?

Throughout pregnancy

During 10-13 weeks

During 14-24th week

Is test invasive?


Yes, cells are taking from the placenta

Yes, amniotic fluid is removed with a syringe

Risk to pregnancy


1-3% risk of miscarriage

1% risk of miscarriage

Accuracy determining gender

At 7 weeks, male baby 95.4%, female 98.6%

100% at 10-13 weeks

100% at 14-24 weeks

Figure 1. Free Cell DNA Compared with Conventional Procedures (from

Below are the following that Free Cell DNA can detect:

  • Paternity
  • Rh blood group typing
  • Hemophilia
  • Duchenne's muscular dystrophy
  • Congenital adrenal hyperplasia

Free Cell Methods

Step 1: cffDNA Purification

The protocols for the separation of plasma from the maternal blood include the following in order: centrifugation, isolation, purification. Formaldehyde is added to the maternal blood to increase the free fetal DNA’s percentage. The formaldehyde’s purpose addition is to steady the intact cells and hinders additional release of maternal DNA. Free fetal DNA’s mean percentage in maternal blood without formaldehyde treatment is 0.40%. However, with formaldehyde treatment the percentage is 20.2%.

There is another way of increasing the DNA and it is based on the fragments’ physical length. A consistent size fractionation can be up to 70% of total cffDNA.

Step 2: Fetal DNA Specification and Detection of Mutation

The following list is some of the procedure to detect paternally inherited sequences. Primers are designed to target the Y-chromosome of male babies/fetuses for PCR.

  • Real-time Quantitative Polymerase Chain Reaction
    In the PCR process, fluorescent investigations are being used to observe the accumulations of amplicons. If there is an increase in fluorescent signal then there’s also an increase in generated amplicons. The appropriate Polymerase Chain Reaction protocol is designed to the specific genotype or mutation to be detected.
  • Nested PCR
    This procedure detects the Y-chromosomes in maternal plasma’s fetal DNA. The results yield that 3 out of 25 pregnant women with female fetuses has a specific signal of Y chromosome. 53 out of 55 male fetuses are also detected. It means that the procedure will have 88% specificity and 96% sensitivity.
  • Digital PCR
    In this procedure; copy number variation, point mutations and loss of aneuploidy and heterozygosis is detectable. It is because of microfluidic devices which perform highly parallel analysis. Digital Polymerase Chain Reaction can give distinction between blood and fetal DNA.
  • Shotgun Sequencing
    This procedure is doable with Illumina/Solexa platform. This method was able to detect trisomy, aneuploidy pregnancies, and gestational ages. This procedure has 97.9% specificity and 100% sensitivity.
  • Mass Spectrometry
    After PCR, fetal DNA can be detected with a specificity of single base and molecule sensitivity through matrix-assisted laser desorption combined with base extension. The DNA is amplified first by PCR. After that, linear amplification is designed to strengthen to the mutation site’s area.
    MALDI-TOF (matrix assisted desorption ionization/time of flight mass) mass spectrometry has 98% sensitivity and 99.1% accuracy.
  • Epigenetic Modifications
    This procedure is used to detect cffDNA. After detecting the cffDNA, it is extracted from the plasma then digested with methylation-sensitive/insensitive enzymes. In one of the tests, 88% of maternal blood samples were detected.
Blood test to determine gender

The tests are purely scientific; however, the process should be understood if you are planning to take some tests like these. Cell-free fetal DNA is not just for gender detection only, the procedure, as I’ve said, could be used to test Down syndrome, Edwards’s syndrome and Patau syndrome and other chromosomal disorders. These are some of the companies that ran this test: Natera’s Panorama, Ariosa Diagnostics’ Harmony, Sequenom’s MaterniT21 and Verinata’s Verifi. Usually, the results are available 7-10 days after you took the test. However, you should remember that it’s your choice to take the test after your genetic counseling.

If you are to take the test for baby’s gender alone, then the result would be enough for you. However, if the screening test you are taking is in a package which includes screening for chromosomal disorder then there are limitations. This test is only blood test so the results should be confirmed still with CVS or Amniocentesis. The test would be less accurate if the woman is pregnant with twins or triplets or women who are mildly obese for the reason that fewer fragments of DNA could be found in their blood.

I hope that you find this article very informative. If you are planning to take the test, remember the advantages it has and its limitations. If you have comments and further questions, inquire on the comment box below. Blood test to determine gender is a new method. May you be excited with your baby’s gender!


Emma Kelley

I am a housewife. I have a nearly one-year-old daughter. My preference is to raise kids and helping people develop skills in parenting.

Click Here to Leave a Comment Below 0 comments